Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Disease Progression”

1,571 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,571 results

Not applicableNot Yet RecruitingNCT07581288
What this trial is testing

Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

Who this might be right for
Uterine BleedingUterine CancerUterine Neoplasms+5 more
University of British Columbia 50
Testing effectiveness (Phase 2)UnknownNCT05942573
What this trial is testing

Continuation of Serplulimab Plus Chemotherapy After First Progression in Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma: an Open-label, Randomised Phase II Trial

Who this might be right for
Gastric Cancer (GC) Gastroesophageal Junction Cancer (GEJ)
Tianjin Medical University Cancer Institute and Hospital 107
Post-approval studies (Phase 4)Looking for participantsNCT05663242
What this trial is testing

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

Who this might be right for
Lung CancerProgression, DiseaseAnesthesia
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT01285817
What this trial is testing

A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.

Who this might be right for
Survival Without Progression
Assistance Publique Hopitaux De Marseille 79
Testing effectiveness (Phase 2)UnknownNCT00530140
What this trial is testing

Idiotypic Vaccination for Follicular Lymphoma Patients

Who this might be right for
Follicular LymphomaFirst Relapse/Progression
Clinica Universidad de Navarra, Universidad de Navarra 100
Testing effectiveness (Phase 2)Study completedNCT02103062
What this trial is testing

Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Celgene 41
Large-scale testing (Phase 3)Study completedNCT02053610
What this trial is testing

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Looking for participantsNCT01042379
What this trial is testing

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Who this might be right for
Breast NeoplasmsBreast CancerBreast Tumors+8 more
QuantumLeap Healthcare Collaborative 5,000
Testing effectiveness (Phase 2)Ended earlyNCT03099486
What this trial is testing

Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC

Who this might be right for
Colorectal Cancer
Fox Chase Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Large-scale testing (Phase 3)Looking for participantsNCT07106762
What this trial is testing

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Who this might be right for
Urothelial Cancer
Bristol-Myers Squibb 470
Not applicableUnknownNCT03309722
What this trial is testing

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

Who this might be right for
Colorectal Cancer
University of Southampton 1,000
Not applicableLooking for participantsNCT06170177
What this trial is testing

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Who this might be right for
Muscle-Invasive Bladder CarcinomaMuscle Invasive Bladder Urothelial CarcinomaBladder Cancer TNM Staging+14 more
IRCCS San Raffaele 4,000
Large-scale testing (Phase 3)Looking for participantsNCT07062965
What this trial is testing

Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Who this might be right for
Breast Cancer
Pfizer 400
Not applicableUnknownNCT05310305
What this trial is testing

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Immune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more
Lei Li 20
Testing effectiveness (Phase 2)UnknownNCT03799094
What this trial is testing

Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clifford Hospital, Guangzhou, China 150
Testing effectiveness (Phase 2)Study completedNCT00077428
What this trial is testing

Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Salivary Gland CancerSalivary Gland Adenoid Cystic Carcinoma+4 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Temporarily pausedNCT01988831
What this trial is testing

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Who this might be right for
Stages III Skin MelanomaStages II Skin MelanomaStage IB Skin Melanoma
University Hospital, Geneva 450
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Early research (Phase 1)UnknownNCT05942508
What this trial is testing

A Phase Ib Study of TQB2450 Combined With Anlotinib in Patients With Limited Stage Small Cell Lung Cancer After First-line Radiotherapy and Chemotherapy

Who this might be right for
Limited Stage Small Cell Lung CancerNot Progressed After First-line Chemoradiotherapy
Jinming Yu 20
Next Page